BioSpace News Archive

Drug Development

6 Months After Pfizer Cuts Neuroscience Development, Adds $600 Million to Venture Arm with 25% Slated for Neuroscience

Pfizer is now throwing an additional $600 million into its venture capital fund, with a quarter of it earmarked for neuroscience research investments.

June 6, 2018
·
2 min read
·
Mark Terry
Biotech Bay

Cancer Research, Medical Records Targeted by Amazon Mystery Initiative

The secret group within Amazon working on a series of bold projects is starting to become a little less secret.

June 6, 2018
·
2 min read
·
Don McCormick
Biotech Beach

Metacrine Closes $65 Million Series C Round

Metracrine, based in San Diego, completed a Series C financing round worth $65 million.

June 6, 2018
·
3 min read
·
Mark Terry
Business

Rob Reiner Kicks Off Day 3 of BIO Convention

Actor, director and advocate Rob Reiner opened the third day of the 2018 BIO International Convention.

June 6, 2018
·
2 min read
·
Don McCormick
“Patient-Centricity”or “Pay-Per-Results” Is a Hot Topic

One of the hot topics at this year’s BIO International Convention being held in Boston is “patient-centricity.”

June 6, 2018
·
3 min read
·
Mark Terry
Biotech Bay

California Life Science Sector Workforce Trends Report: Amgen, Pfizer and Genentech Leading Employers in the State

The Biocom Institute and California Life Sciences Institute (CLSI) released their third biennial life science industry report. Overall, the report paints a very positive picture of the life science industry in California.

June 6, 2018
·
4 min read
·
Mark Terry